NovaLaka

Slow-release Transmucosal Drug Delivery Systems

Health Tech & Life Sciences
Non Active, Dec 2019 ceased to operate
Seed Jerusalem Founded 2015
LinkedIn
Total raised
$57K
Last: Seed 2017-05
Stage
Seed
Founded
2015
Headcount
1
HQ
Jerusalem
Sector
Health Tech & Life Sciences

About

NovaLaka develops technology in the field of slow-release drug-delivery systems, specializing in transmucosal solutions for women's healthcare applications. The company has developed a polymeric composition that serves as a drug-delivery system specifically designed for mucosal tissue such as the eyes. The polymeric matrix gradually releases the desired medication directly to the area requiring treatment. NovaLaka's polymeric film can serve as a vehicle for any active ingredient, delivering it directly through the tissue effectively and in a controlled manner. In 2017, NovaLaka won the first prize at the Global Pitch of China.

Funding history · 1 round · $57K total

2017-05
Seed $57K

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
ConsumersDemographics & FamilyWomenHealthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

polymerssustained-releaseburnstopical-treatmentdrug-deliverypharmaceuticalspharma-companies